COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Income Growth Analysis including revenue, gross profit, operating profit, net profit, EPS, and other financial metrics. Compare income growth against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Income Growth Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.

Revenue Growth

9.16%

Increased from previous period

Growth of 9.16% versus flat Healthcare revenue. Walter Schloss would verify growth quality.

Cost of Revenue Growth

8.72%

Increased from previous period

Cost growth of 8.72% versus flat Healthcare costs. Walter Schloss would verify cost control.

Gross Profit Growth

10.92%

Increased from previous period

Growth of 10.92% versus flat Healthcare gross profit. Walter Schloss would verify quality.

Gross Margin Ratio Growth

1.61%

Increased from previous period

Margin change of 1.61% versus flat Healthcare margins. Walter Schloss would verify quality.

R&D Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

G&A Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

Selling & Marketing Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

Other Expenses Growth

22.22%

Increased from previous period

Other expenses change of 22.22% versus flat Healthcare costs. Walter Schloss would verify efficiency.

Operating Expenses Growth

0.94%

Decreased from previous period

Operating expenses change of 0.94% versus flat Healthcare costs. Walter Schloss would verify control.

Total Costs & Expenses Growth

7.33%

Increased from previous period

Total costs change of 7.33% versus flat Healthcare costs. Walter Schloss would verify control.

Interest Expense Growth

43.33%

Increased from previous period

Interest expense change of 43.33% versus flat Healthcare costs. Walter Schloss would verify control.

Depreciation & Amortization Growth

48.66%

Increased from previous period

D&A change of 48.66% versus flat Healthcare D&A. Walter Schloss would verify adequacy.

EBITDA Growth

66.79%

Increased from previous period

EBITDA change of 66.79% versus flat Healthcare. Walter Schloss would verify quality.

EBITDA Margin Growth

52.80%

Increased from previous period

Margin change of 52.80% versus flat Healthcare. Walter Schloss would verify quality.

Operating Income Growth

81.54%

Increased from previous period

Income change of 81.54% versus flat Healthcare. Walter Schloss would verify quality.

Operating Margin Growth

66.31%

Increased from previous period

Margin change of 66.31% versus flat Healthcare. Walter Schloss would verify quality.

Other Income/Expenses Growth

10.78%

Increased from previous period

Other expenses change of 10.78% versus flat Healthcare. Walter Schloss would verify control.

Pre-Tax Income Growth

72.16%

Increased from previous period

Income change of 72.16% versus flat Healthcare. Walter Schloss would verify quality.

Pre-Tax Margin Growth

57.72%

Increased from previous period

Margin change of 57.72% versus flat Healthcare. Walter Schloss would verify quality.

Income Tax Expense Growth

70.58%

Increased from previous period

Tax expense change of 70.58% versus flat Healthcare. Walter Schloss would verify strategy.

Net Income Growth

73.81%

Increased from previous period

Income change of 73.81% versus flat Healthcare. Walter Schloss would verify quality.

Net Margin Growth

59.23%

Increased from previous period

Margin change of 59.23% versus flat Healthcare. Walter Schloss would verify quality.

EPS Growth

75.54%

Increased from previous period

EPS change of 75.54% versus flat Healthcare. Walter Schloss would verify quality.

Diluted EPS Growth

75.54%

Increased from previous period

Diluted EPS change of 75.54% versus flat Healthcare. Walter Schloss would verify quality.

Share Count Growth (Basic)

No Data

No Data available this quarter, please select a different quarter.

Share Count Growth (Diluted)

No Data

No Data available this quarter, please select a different quarter.

Select Chart Metric:

3349.T Income Growth Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Revenue Growth

9.16%

Increased from previous period

Growth of 9.16% versus flat Healthcare revenue. Walter Schloss would verify growth quality.

Cost of Revenue Growth

8.72%

Increased from previous period

Cost growth of 8.72% versus flat Healthcare costs. Walter Schloss would verify cost control.

Gross Profit Growth

10.92%

Increased from previous period

Growth of 10.92% versus flat Healthcare gross profit. Walter Schloss would verify quality.

Gross Margin Ratio Growth

1.61%

Increased from previous period

Margin change of 1.61% versus flat Healthcare margins. Walter Schloss would verify quality.

R&D Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

G&A Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

Selling & Marketing Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

Other Expenses Growth

22.22%

Increased from previous period

Other expenses change of 22.22% versus flat Healthcare costs. Walter Schloss would verify efficiency.

Operating Expenses Growth

0.94%

Decreased from previous period

Operating expenses change of 0.94% versus flat Healthcare costs. Walter Schloss would verify control.

Total Costs & Expenses Growth

7.33%

Increased from previous period

Total costs change of 7.33% versus flat Healthcare costs. Walter Schloss would verify control.

Interest Expense Growth

43.33%

Increased from previous period

Interest expense change of 43.33% versus flat Healthcare costs. Walter Schloss would verify control.

Depreciation & Amortization Growth

48.66%

Increased from previous period

D&A change of 48.66% versus flat Healthcare D&A. Walter Schloss would verify adequacy.

EBITDA Growth

66.79%

Increased from previous period

EBITDA change of 66.79% versus flat Healthcare. Walter Schloss would verify quality.

EBITDA Margin Growth

52.80%

Increased from previous period

Margin change of 52.80% versus flat Healthcare. Walter Schloss would verify quality.

Operating Income Growth

81.54%

Increased from previous period

Income change of 81.54% versus flat Healthcare. Walter Schloss would verify quality.

Operating Margin Growth

66.31%

Increased from previous period

Margin change of 66.31% versus flat Healthcare. Walter Schloss would verify quality.

Other Income/Expenses Growth

10.78%

Increased from previous period

Other expenses change of 10.78% versus flat Healthcare. Walter Schloss would verify control.

Pre-Tax Income Growth

72.16%

Increased from previous period

Income change of 72.16% versus flat Healthcare. Walter Schloss would verify quality.

Pre-Tax Margin Growth

57.72%

Increased from previous period

Margin change of 57.72% versus flat Healthcare. Walter Schloss would verify quality.

Income Tax Expense Growth

70.58%

Increased from previous period

Tax expense change of 70.58% versus flat Healthcare. Walter Schloss would verify strategy.

Net Income Growth

73.81%

Increased from previous period

Income change of 73.81% versus flat Healthcare. Walter Schloss would verify quality.

Net Margin Growth

59.23%

Increased from previous period

Margin change of 59.23% versus flat Healthcare. Walter Schloss would verify quality.

EPS Growth

75.54%

Increased from previous period

EPS change of 75.54% versus flat Healthcare. Walter Schloss would verify quality.

Diluted EPS Growth

75.54%

Increased from previous period

Diluted EPS change of 75.54% versus flat Healthcare. Walter Schloss would verify quality.

Share Count Growth (Basic)

No Data

No Data available this quarter, please select a different quarter.

Share Count Growth (Diluted)

No Data

No Data available this quarter, please select a different quarter.

Select Chart Metric: